Manage your Account and Access Personalized Content.
We offer detail market analysis for the potential growth of opportunities in the market.
We are committed to provide top quality customized reports.
Detail behavioral analysis to meet customers’ needs.
Take a look at our efforts, development and successes.
A blog is strongest tool that showcase our offerings and products.
Implementing and dealing with all the latest research possibilities along with finding new patterns and trends in data.
We provide in-depth investigation of the market with quantitative and qualitative research tools.
Author: QYResearch | Published Date: 2018-05-31 | Views: 46
About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation.
This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2018 to 2025.
The geographical segmentation includes North America, Europe, Asia-Pacific, South America and Middle East & Africa. North America holds the largest share in this market. However, Asia-Pacific is expected to witness the highest growth rate owing to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.
The major players in global Atrial Fibrillation Devices market include
St. Jude Medical
©2019 QY Research All Rights Reserved.